Marco Macagno

954 total citations
15 papers, 532 citations indexed

About

Marco Macagno is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Marco Macagno has authored 15 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Marco Macagno's work include Immunotherapy and Immune Responses (5 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Cells and Metastasis (3 papers). Marco Macagno is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Cells and Metastasis (3 papers). Marco Macagno collaborates with scholars based in Italy, Belarus and Austria. Marco Macagno's co-authors include Massimo Aglietta, Dario Sangiolo, Marco Merlano, Luca Bertolaccini, Cristiana Lo Nigro, Federica Cavallo, Stefania Lanzardo, Laura Conti, Maddalena Arigoni and Roberto Ruiu and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Marco Macagno

15 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Macagno Italy	12	291	260	180	97	52	15	532
Mariano F. Zacarías Fluck Spain	8	186 0.6×	236 0.9×	176 1.0×	87 0.9×	35 0.7×	15	463
Christie Fanton United States	11	267 0.9×	288 1.1×	198 1.1×	36 0.4×	32 0.6×	26	587
Mai-Britt Zocca Denmark	15	509 1.7×	348 1.3×	268 1.5×	57 0.6×	32 0.6×	25	718
Ravindra Uppaluri United States	10	390 1.3×	313 1.2×	159 0.9×	62 0.6×	44 0.8×	25	590
Peiying Ye China	9	256 0.9×	275 1.1×	180 1.0×	71 0.7×	35 0.7×	16	515
Hayrettin Guvén Sweden	13	358 1.2×	329 1.3×	195 1.1×	62 0.6×	33 0.6×	17	654
Christopher Taylor United States	3	206 0.7×	179 0.7×	156 0.9×	58 0.6×	27 0.5×	6	494
Ewa Cendrowicz Netherlands	7	237 0.8×	177 0.7×	179 1.0×	63 0.6×	57 1.1×	11	480
Ryota Kondou Japan	9	186 0.6×	229 0.9×	105 0.6×	38 0.4×	33 0.6×	18	358
Jane Antony United States	10	165 0.6×	185 0.7×	207 1.1×	79 0.8×	46 0.9×	16	448

Countries citing papers authored by Marco Macagno

Since Specialization

Citations

This map shows the geographic impact of Marco Macagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Macagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Macagno more than expected).

Fields of papers citing papers by Marco Macagno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Macagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Macagno. The network helps show where Marco Macagno may publish in the future.

Co-authorship network of co-authors of Marco Macagno

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Macagno. A scholar is included among the top collaborators of Marco Macagno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Macagno. Marco Macagno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Maione, Federica, Daniele Oddo, Chiara Falcomatà, et al.. (2024). Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models. Molecular Oncology. 18(6). 1552–1570. 4 indexed citations

Macagno, Marco, Elisabetta Bolli, Federica Riccardo, et al.. (2022). Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines. 10(2). 230–230. 1 indexed citations

Bizzozero, Laura, Federica Maione, Elena Maldi, et al.. (2022). The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 266–266. 20 indexed citations

Nicolazzo, Chiara, Ludovic Barault, S Caponnetto, et al.. (2021). True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature. Cancer Letters. 507. 89–96. 20 indexed citations

Nicolazzo, Chiara, Ludovic Barault, S Caponnetto, et al.. (2020). Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients. Cancers. 12(12). 3633–3633. 10 indexed citations

Nigro, Cristiana Lo, Marco Macagno, Dario Sangiolo, et al.. (2019). NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives. Annals of Translational Medicine. 7(5). 105–105. 165 indexed citations

Sanlorenzo, Martina, Igor Vujic, Mauro Novelli, et al.. (2018). BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody. Clinical Cancer Research. 24(14). 3377–3385. 30 indexed citations

Pastò, Anna, Matteo Curtarello, Maddalena Arigoni, et al.. (2016). A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model. Oncotarget. 7(22). 33081–33095. 15 indexed citations

Macagno, Marco, Stefania Lanzardo, Laura Conti, et al.. (2016). The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis. OncoImmunology. 5(12). e1253653–e1253653. 35 indexed citations

10.

Lanzardo, Stefania, Laura Conti, Ronald Rooke, et al.. (2015). Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. Cancer Research. 76(1). 62–72. 103 indexed citations

11.

Macagno, Marco, Elena Quaglino, Laura Conti, et al.. (2014). Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice. The Journal of Immunology. 192(11). 5434–5441. 16 indexed citations

12.

Riccardo, Federica, Elisabetta Bolli, Marco Macagno, et al.. (2014). Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. Current topics in microbiology and immunology. 405. 99–122. 22 indexed citations

13.

Conti, Laura, Roberto Ruiu, Giuseppina Barutello, et al.. (2014). Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice. BioMed Research International. 2014. 1–16. 29 indexed citations

14.

Curcio, Claudia, Marco Macagno, Elena Quaglino, et al.. (2013). Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice. OncoImmunology. 2(9). e26137–e26137. 41 indexed citations

15.

Quaglino, Elena, Federica Riccardo, Marco Macagno, et al.. (2011). Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. Cancers. 3(3). 3225–3241. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact